This inventor holds 1 USPTO granted patent. Top assignee: Sanofi-Synthelabo. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: The Innovations of Georges Daste
Introduction
Georges Daste is a notable inventor based in Bordeaux, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antithrombotic and antiatherogenic compositions. His work has implications for cardiovascular health and the treatment of related conditions.
Latest Patents
Georges Daste holds a patent for an innovative pharmaceutical composition that includes a thienopyridine derivative and an HMG-CoA-reductase inhibitor. This patent is crucial for advancing treatments that target blood clotting and cholesterol management. He has 1 patent to his name, showcasing his expertise in this specialized area.
Career Highlights
Daste is associated with Sanofi-Synthelabo, a leading global healthcare company. His role at the company has allowed him to work on groundbreaking research and development projects. His contributions have been instrumental in enhancing the company's portfolio in the pharmaceutical sector.
Collaborations
Georges Daste collaborates with Jean Marc Herbert, a fellow professional in the field. Their partnership exemplifies the importance of teamwork in driving innovation and achieving successful outcomes in research.
Conclusion
Georges Daste's work in pharmaceuticals highlights the impact of innovative thinking in healthcare. His patent and collaboration efforts contribute to advancements that can improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile